Richard D. Francis, President and CEO at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 56,234 shares at $15.56 ($906K) on 2025-03-04, disclosed to the SEC on 2025-03-05.
Scheduled sale ($906k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.19 | 24,892 | $403K | 44.5% |
| 2 | $16.19 | 24,892 | $403K | 44.5% |
| 3 | $15.56 | 6,450 | $100K | 11.1% |
| Total | $16.12 avg | 56,234 | $906K | 100% |
| Filing → |
| TEVA | SELL | 2026-03-06 | $1.5M | — | Filing → |
| TEVA | SELL | 2026-03-05 | $28.7M | — | Filing → |
| TEVA | SELL | 2026-02-18 | $30.6M | — | Filing → |